| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.33 | 0.07 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.34 | 0.07 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |